The B.1.526 variant of SARS-CoV-2, also known as the lota variant, was first identified in New York City in November 2020. Later, the variant has been detected in all 52 states in the United States, as well as in 27 countries across the world. It carries two mutations that concern scientists.
A study conducted in the US shows that this variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults.
B.1.526 variant increases the infection fatality rates by 46%, 82%, and 62% in individuals aged 45 – 64 years, 65 – 74 years, and above 75 years, respectively. Compared to previously circulating variants, the B.1.526 variant, overall, caused a 60% induction in the infection fatality rate.
A study conducted in the US shows that this variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults.
B.1.526 variant increases the infection fatality rates by 46%, 82%, and 62% in individuals aged 45 – 64 years, 65 – 74 years, and above 75 years, respectively. Compared to previously circulating variants, the B.1.526 variant, overall, caused a 60% induction in the infection fatality rate.
